Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 1 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2022 Filed Aug 4, 2022 20:38 UTC |
Guerin Mark PatrickCFO AND COO
|
Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-008261 · form4-08042022_010847.xml · derivative · entry 3 Guerin Mark Patrick · CIK 0001607714 · CFO AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On August 2, 2021 the reporting person was granted 14,250 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: On August 2, 2021 the reporting person was granted 14,250 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:38 UTC |
Guerin Mark PatrickCFO AND COO
|
Exercise / conversionCommon Stock | 4,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-008261 · form4-08042022_010847.xml · nonDerivative · entry 1 Guerin Mark Patrick · CIK 0001607714 · CFO AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:34 UTC |
Gelder Mark S. MDCHIEF MEDICAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 4,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-008260 · form4-08042022_010823.xml · derivative · entry 3 Gelder Mark S. MD · CIK 0001564390 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,300 Underlying: Common Stock · 4,650 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On August 2, 2021 the reporting person was granted 13,950 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: On August 2, 2021 the reporting person was granted 13,950 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:34 UTC |
Gelder Mark S. MDCHIEF MEDICAL OFFICER
|
Exercise / conversionCommon Stock | 4,650 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-008260 · form4-08042022_010823.xml · nonDerivative · entry 1 Gelder Mark S. MD · CIK 0001564390 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:30 UTC |
Fruchtman Steven MDirector · PRESIDENT, CHIEF EXECUTIVE OFF
|
Exercise / conversionRestricted Stock Units · Derivative | 12,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-008258 · form4-08042022_010852.xml · derivative · entry 3 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,134 Underlying: Common Stock · 12,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On August 2, 2021 the reporting person was granted 37,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: On August 2, 2021 the reporting person was granted 37,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 20:30 UTC |
Fruchtman Steven MDirector · PRESIDENT, CHIEF EXECUTIVE OFF
|
Exercise / conversionCommon Stock | 12,566 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-008258 · form4-08042022_010852.xml · nonDerivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · PRESIDENT, CHIEF EXECUTIVE OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 20:03 UTC |
Guerin Mark PatrickCOO and CFO
|
GrantRestricted Stock Units · Derivative | 16,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003288 · edgar.xml · derivative · entry 2 Guerin Mark Patrick · CIK 0001607714 · COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common stock · 16,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock. F2 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 20:03 UTC |
Guerin Mark PatrickCOO and CFO
|
GrantStock Option (right to purchase) · Derivative | 50,250 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0001179110-22-003288 · edgar.xml · derivative · entry 1 Guerin Mark Patrick · CIK 0001607714 · COO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,250 Underlying: Common stock · 50,250 shares Expires 2032-06-10 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:52 UTC |
Gelder Mark S. MDChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000964 · edgar.xml · derivative · entry 2 Gelder Mark S. MD · CIK 0001564390 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common stock · 17,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock. F2 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:52 UTC |
Gelder Mark S. MDChief Medical Officer
|
GrantStock Option (right to purchase) · Derivative | 51,750 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001179110-22-000964 · edgar.xml · derivative · entry 1 Gelder Mark S. MD · CIK 0001564390 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,750 Underlying: Common stock · 51,750 shares Expires 2032-02-07 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:41 UTC |
Fruchtman Steven MDirector · President, Chief Executive Off
|
GrantRestricted Stock Units · Derivative | 63,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000963 · edgar.xml · derivative · entry 2 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,960 Underlying: Common stock · 63,960 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock. F2 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:41 UTC |
Fruchtman Steven MDirector · President, Chief Executive Off
|
GrantStock Option (right to purchase) · Derivative | 191,880 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001179110-22-000963 · edgar.xml · derivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,880 Underlying: Common stock · 191,880 shares Expires 2032-02-07 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:38 UTC |
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel
|
GrantRestricted Stock Units · Derivative | 17,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000962 · edgar.xml · derivative · entry 2 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,633 Underlying: Common stock · 17,633 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock. F2 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:38 UTC |
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel
|
GrantStock Option (right to purchase) · Derivative | 54,050 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001179110-22-000962 · edgar.xml · derivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,050 Underlying: Common stock · 54,050 shares Expires 2032-02-07 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:33 UTC |
Guerin Mark PatrickChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 20,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000961 · edgar.xml · derivative · entry 2 Guerin Mark Patrick · CIK 0001607714 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,700 Underlying: Common stock · 20,700 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock. F2 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 21:33 UTC |
Guerin Mark PatrickChief Financial Officer
|
GrantStock Option (right to purchase) · Derivative | 62,100 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001179110-22-000961 · edgar.xml · derivative · entry 1 Guerin Mark Patrick · CIK 0001607714 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,100 Underlying: Common stock · 62,100 shares Expires 2032-02-07 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| January 28, 2022 Filed Jan 31, 2022 13:41 UTC |
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel
|
PurchaseCommon Stock | 1,500 | $1.67 | $2,505.00 |
DisclosureSEC source: 0001179110-22-000652 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,514 F1 · kind: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
| January 21, 2022 Filed Jan 24, 2022 13:40 UTC |
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel
|
PurchaseCommon Stock | 1,500 | $2.02 | $3,030.00 |
DisclosureSEC source: 0001179110-22-000564 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,014 F1 · kind: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
| January 14, 2022 Filed Jan 18, 2022 14:12 UTC |
OLER ABRAHAM N.SVP CORP DEV & GEN COUNSEL
|
PurchaseCommon Stock | 1,500 | $2.20 | $3,300.00 |
DisclosureSEC source: 0001415889-22-000588 · form4-01182022_060148.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP CORP DEV & GEN COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,514 F1 · kind: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
| January 07, 2022 Filed Jan 10, 2022 13:39 UTC |
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel
|
PurchaseCommon Stock | 1,500 | $2.39 | $3,585.00 |
DisclosureSEC source: 0001179110-22-000350 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,014 F1 · kind: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 14:20 UTC |
OLER ABRAHAM N.SVP CORP DEV & GEN COUNSEL
|
PurchaseCommon stock | 1,000 | $3.16 | $3,160.00 |
DisclosureSEC source: 0001415889-21-005425 · form4-11232021_061136.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP CORP DEV & GEN COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,514 F1 · balance_after: Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 13:45 UTC |
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel
|
OtherWarrant (right to purchase) · Derivative | 5,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001179110-21-010259 · edgar.xml · derivative · entry 2 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2024-11-25 F2 · shares: The warrants were acquired in the November 2019 public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 13:45 UTC |
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel
|
OtherCommon Stock | 5,000 | $3.00 | $15,000.00 |
DisclosureSEC source: 0001179110-21-010259 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,514 F1 · balance_after: Includes 9,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
| September 28, 2021 Filed Sep 28, 2021 16:34 UTC |
Fruchtman Steven MDirector · President, Chief Executive Off
|
PurchaseCommon Stock | 2,381 | $4.20 | $10,000.20 |
DisclosureSEC source: 0001179110-21-008956 · edgar.xml · nonDerivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,130 Read SEC document |
| September 28, 2021 Filed Sep 28, 2021 16:32 UTC |
MARINO JAMES JDirector
|
PurchaseCommon Stock | 5,952 | $4.20 | $24,998.40 |
DisclosureSEC source: 0001179110-21-008955 · edgar.xml · nonDerivative · entry 1 MARINO JAMES J · CIK 0001198578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,334 Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 12:27 UTC |
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel
|
PurchaseCommon Stock | 2,381 | $4.20 | $10,000.20 |
DisclosureSEC source: 0001179110-21-008982 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,515 F1 · balance_after: Includes 4,334 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 12:25 UTC |
Gelder Mark S. MDChief Medical Officer
|
PurchaseCommon Stock | 2,381 | $4.20 | $10,000.20 |
DisclosureSEC source: 0001179110-21-008981 · edgar.xml · nonDerivative · entry 1 Gelder Mark S. MD · CIK 0001564390 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,381 Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:04 UTC |
Fruchtman Steven MDirector · President, Chief Executive Off
|
GrantRestricted Stock Unit · Derivative | 37,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007925 · edgar.xml · derivative · entry 2 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,700 Underlying: Common stock · 37,700 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock. F2 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:04 UTC |
Fruchtman Steven MDirector · President, Chief Executive Off
|
GrantStock Option (right to purchase) · Derivative | 113,000 | $0.00 Strike: $5.19 | $0.00 |
DisclosureSEC source: 0001179110-21-007925 · edgar.xml · derivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,000 Underlying: Common stock · 113,000 shares Expires 2031-08-02 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:02 UTC |
Gelder Mark S. MDChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 13,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007924 · edgar.xml · derivative · entry 2 Gelder Mark S. MD · CIK 0001564390 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,950 Underlying: Common stock · 13,950 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock. F2 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:02 UTC |
Gelder Mark S. MDChief Medical Officer
|
GrantStock Option (right to purchase) · Derivative | 41,825 | $0.00 Strike: $5.19 | $0.00 |
DisclosureSEC source: 0001179110-21-007924 · edgar.xml · derivative · entry 1 Gelder Mark S. MD · CIK 0001564390 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,825 Underlying: Common stock · 41,825 shares Expires 2031-08-02 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:01 UTC |
Guerin Mark PatrickChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 14,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007923 · edgar.xml · derivative · entry 2 Guerin Mark Patrick · CIK 0001607714 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,250 Underlying: Common stock · 14,250 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock. F2 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| August 02, 2021 Filed Aug 5, 2021 00:01 UTC |
Guerin Mark PatrickChief Financial Officer
|
GrantStock Option (right to purchase) · Derivative | 42,750 | $0.00 Strike: $5.19 | $0.00 |
DisclosureSEC source: 0001179110-21-007923 · edgar.xml · derivative · entry 1 Guerin Mark Patrick · CIK 0001607714 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,750 Underlying: Common stock · 42,750 shares Expires 2031-08-02 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 23:12 UTC |
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel
|
GrantRestricted Stock Units · Derivative | 13,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007922 · edgar.xml · derivative · entry 2 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,400 Underlying: Common stock · 13,400 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit is convertible into one share of common stock. F2 · derivative.exercise_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. F2 · derivative.expiration_date: These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 23:12 UTC |
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel
|
GrantStock Option (right to purchase) · Derivative | 40,000 | $0.00 Strike: $5.19 | $0.00 |
DisclosureSEC source: 0001179110-21-007922 · edgar.xml · derivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common stock · 40,000 shares Expires 2031-08-02 F1 · derivative.exercise_date: These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Read SEC document |
| July 30, 2021 Filed Jul 30, 2021 23:11 UTC |
GROOPMAN JEROMEDirector
|
GrantStock Option (right to purchase) · Derivative | 13,000 | $0.00 Strike: $4.97 | $0.00 |
DisclosureSEC source: 0001179110-21-007788 · edgar.xml · derivative · entry 1 GROOPMAN JEROME · CIK 0001218853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common stock · 13,000 shares Expires 2031-07-30 F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date. Read SEC document |
| July 30, 2021 Filed Jul 30, 2021 23:21 UTC |
STOVER JACK EDirector
|
GrantStock Option (right to purchase) · Derivative | 13,000 | $0.00 Strike: $4.97 | $0.00 |
DisclosureSEC source: 0001179110-21-007792 · edgar.xml · derivative · entry 1 STOVER JACK E · CIK 0001203603 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 13,000 shares Expires 2031-07-30 F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date. Read SEC document |
| July 30, 2021 Filed Jul 30, 2021 23:19 UTC |
Shoemaker Mary TeresaDirector
|
GrantStock Option (right to purchase) · Derivative | 13,000 | $0.00 Strike: $4.97 | $0.00 |
DisclosureSEC source: 0001179110-21-007791 · edgar.xml · derivative · entry 1 Shoemaker Mary Teresa · CIK 0001813552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common stock · 13,000 shares Expires 2031-07-30 F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date. Read SEC document |
| July 30, 2021 Filed Jul 30, 2021 23:16 UTC |
MEHTA VIRENDirector
|
GrantStock Option (right to purchase) · Derivative | 13,000 | $0.00 Strike: $4.97 | $0.00 |
DisclosureSEC source: 0001179110-21-007790 · edgar.xml · derivative · entry 1 MEHTA VIREN · CIK 0001238969 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common stock · 13,000 shares Expires 2031-07-30 F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date. Read SEC document |
| July 30, 2021 Filed Jul 30, 2021 23:12 UTC |
MARINO JAMES JDirector
|
GrantStock Option (right to purchase) · Derivative | 13,000 | $0.00 Strike: $4.97 | $0.00 |
DisclosureSEC source: 0001179110-21-007789 · edgar.xml · derivative · entry 1 MARINO JAMES J · CIK 0001198578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Underlying: Common stock · 13,000 shares Expires 2031-07-30 F1 · derivative.exercise_date: These options vest 100% on the first anniversary of the grant date. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 23:46 UTC |
Gelder Mark S. MDChief Medical Officer
|
GrantStock Option (right to purchase) · Derivative | 20,000 | $0.00 Strike: $7.56 | $0.00 |
DisclosureSEC source: 0001179110-21-006842 · edgar.xml · derivative · entry 1 Gelder Mark S. MD · CIK 0001564390 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-14 F1 · derivative.exercise_date: Theses options vest over 4 years, 25% on the first anniversary of the grant and thereafter in 36 equal monthly installments over the next 3 years. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:29 UTC |
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel
|
GrantStock Appreciation Right · Derivative | 208,000 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001179110-21-002008 · edgar.xml · derivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,000 Underlying: Common Stock · 208,000 shares Expires 2031-02-17 F1 · derivative.exercise_date: These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. F2 · derivative.underlying: These stock appreciation rights represent the right to receive a cash payment equal to the excess, if any, of (i) the fair market value of each underlying share of the Company's common stock, determined on the date of exercise minus (ii) the exercise price; provided, that in no event may the cash payment for each stock appreciation right exceed $1.03, which is the maximum price per share of $2.54, minus the base amount of $1.51, subject to adjustment in accordance with the terms of the award agreement. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:26 UTC |
Guerin Mark PatrickChief Financial Officer
|
GrantStock Appreciation Right · Derivative | 301,000 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001179110-21-002007 · edgar.xml · derivative · entry 1 Guerin Mark Patrick · CIK 0001607714 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,000 Underlying: Common Stock · 301,000 shares Expires 2031-02-17 F1 · derivative.exercise_date: These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. F2 · derivative.underlying: These stock appreciation rights represent the right to receive a cash payment equal to the excess, if any, of (i) the fair market value of each underlying share of the Company's common stock, determined on the date of exercise minus (ii) the exercise price; provided, that in no event may the cash payment for each stock appreciation right exceed $1.03, which is the maximum price per share of $2.54, minus the base amount of $1.51, subject to adjustment in accordance with the terms of the award agreement. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:25 UTC |
Fruchtman Steven MDirector · President, Chief Executive Off
|
GrantStock Appreciation Right · Derivative | 706,000 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001179110-21-002006 · edgar.xml · derivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 706,000 Underlying: Common Stock · 706,000 shares Expires 2031-02-17 F1 · derivative.exercise_date: These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. F2 · derivative.underlying: These stock appreciation rights represent the right to receive a cash payment equal to the excess, if any, of (i) the fair market value of each underlying share of the Company's common stock, determined on the date of exercise minus (ii) the exercise price; provided, that in no event may the cash payment for each stock appreciation right exceed $1.03, which is the maximum price per share of $2.54, minus the base amount of $1.51, subject to adjustment in accordance with the terms of the award agreement. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 13:57 UTC |
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel
|
PurchaseCommon Stock | 12,000 | $1.00 | $12,000.00 |
DisclosureSEC source: 0001179110-21-001785 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,000 F1 · balance_after: Includes 65,000 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 13:55 UTC |
Guerin Mark PatrickChief Financial Officer
|
PurchaseCommon Stock | 15,000 | $1.00 | $15,000.00 |
DisclosureSEC source: 0001179110-21-001784 · edgar.xml · nonDerivative · entry 1 Guerin Mark Patrick · CIK 0001607714 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,213 Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 13:48 UTC |
Fruchtman Steven MDirector · President, Chief Executive Off
|
PurchaseCommon Stock | 20,000 | $1.00 | $20,000.00 |
DisclosureSEC source: 0001179110-21-001783 · edgar.xml · nonDerivative · entry 1 Fruchtman Steven M · CIK 0001631251 · Director · President, Chief Executive Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,226 Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 13:46 UTC |
MARINO JAMES JDirector
|
PurchaseCommon Stock | 25,000 | $1.00 | $25,000.00 |
DisclosureSEC source: 0001179110-21-001782 · edgar.xml · nonDerivative · entry 1 MARINO JAMES J · CIK 0001198578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,716 Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 13:45 UTC |
Shoemaker Mary TeresaDirector
|
PurchaseCommon Stock | 13,000 | $1.00 | $13,000.00 |
DisclosureSEC source: 0001179110-21-001781 · edgar.xml · nonDerivative · entry 1 Shoemaker Mary Teresa · CIK 0001813552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,735 F1 · balance_after: Includes 37,735 shares held by the M. Teresa Shoemaker Revocable Trust U/A DTD 08/01/2000, of which the reporting person is a trustee. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 14:00 UTC |
OLER ABRAHAM N.SVP Corp Dev & Gen Counsel
|
PurchaseCommon Stock | 30,000 | $0.32 | $9,600.00 |
DisclosureSEC source: 0001179110-20-011839 · edgar.xml · nonDerivative · entry 1 OLER ABRAHAM N. · CIK 0001557372 · SVP Corp Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 F1 · balance_after: Includes 65,000 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.